Beta Bionics, Inc. Increase (Decrease) in Accounts Receivable
Beta Bionics, Inc. (BBNX) reported Increase (Decrease) in Accounts Receivable of $951.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-07-29
- Beta Bionics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $2.32M, a 0.69% decline year-over-year.
- Beta Bionics, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$1.37M.
- Beta Bionics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $5.59M, a 22.75% increase year-over-year.
- Beta Bionics, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $168.00K.
- Beta Bionics, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $5.16M, a 32.24% decline from fiscal 2024.
- Beta Bionics, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $7.62M, a 69.51% increase from fiscal 2023.
- Beta Bionics, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $4.49M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $951.00K 10-Q · filed 2026-07-29 | $6.55M derived: sum of 3 quarters · filed 2026-07-29 | $6.71M derived: sum of 4 quarters · filed 2026-07-29 |
| 2026-03-31 | -$1.37M 10-Q · filed 2026-04-21 | $4.23M derived: sum of 2 quarters · filed 2026-04-21 | $4.39M derived: sum of 3 quarters · filed 2026-04-21 | $6.73M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-12-31 | $5.59M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $5.76M derived: sum of 2 quarters · filed 2026-02-24 | $8.10M derived: sum of 3 quarters · filed 2026-07-29 | $5.16M 10-K · filed 2026-02-24 |
| 2025-09-30 | $168.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $2.50M derived: sum of 2 quarters · filed 2026-07-29 | -$433.00K 10-Q · filed 2025-10-28 | $4.13M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | -$601.00K 10-Q · filed 2026-07-29 | $3.96M derived: sum of 3 quarters · filed 2026-07-29 | $2.46M derived: sum of 4 quarters · filed 2026-07-29 |
| 2025-03-31 | -$2.94M 10-Q · filed 2026-04-21 | $1.62M derived: sum of 2 quarters · filed 2026-04-21 | $126.00K derived: sum of 3 quarters · filed 2026-04-21 | $2.76M derived: sum of 4 quarters · filed 2026-04-21 |
| 2024-12-31 | $4.56M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.06M derived: sum of 2 quarters · filed 2026-02-24 | $5.70M derived: sum of 3 quarters · filed 2026-02-24 | $7.62M 10-K · filed 2026-02-24 |
| 2024-09-30 | -$1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-28 | $1.14M derived: sum of 2 quarters · filed 2025-10-28 | $3.06M 10-Q · filed 2025-10-28 | |
| 2024-06-30 | $2.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-29 | $4.56M 10-Q · filed 2025-07-29 | ||
| 2024-03-31 | $1.92M 10-Q · filed 2025-05-06 | |||
| 2023-12-31 | $4.49M 10-K/A · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |